Hims CFO exercises options, sells 7,163 shares
Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported an option exercise and related share sale in Class A Common Stock.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported an option exercise and related share sale in Class A Common Stock. Okupe exercised stock options to acquire 7,163 shares at a price of $5.0100 per share, then sold 7,163 shares at an average price of $36.4863 per share.
These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on May 21, 2025. Following the transactions, Okupe holds 284,321 shares directly and 7,853 shares indirectly through the Oluyemi Okupe Separate Property Trust dated September 1, 2021, along with 102,361 stock options remaining outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 7,163 shares ($225K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Okupe Oluyemi
Role
Chief Financial Officer
Sold
7,163 shs ($261K)
Approx. gross sale proceeds
$261K
Approx. exercise cost
$36K
Approx. pre-tax spread
$225K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 7,163 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 7,163 | $5.01 | $36K |
| Sale | Class A Common Stock | 7,163 | $36.4863 | $261K |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 102,361 contracts (Direct);
Class A Common Stock — 284,321 shares (Direct);
Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)
Footnotes (3)
- F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.35 - $36.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Key Figures
Shares sold: 7,163 shares
Average sale price: $36.4863 per share
Options exercised: 7,163 options
+5 more
8 metrics
Shares sold
7,163 shares
Class A Common Stock sold in open-market transaction
Average sale price
$36.4863 per share
Weighted average price for 7,163 shares sold
Options exercised
7,163 options
Stock options converted into Class A Common Stock
Option exercise price
$5.0100 per share
Conversion or exercise price of stock options
Direct holdings after transaction
284,321 shares
Class A Common Stock held directly by CFO post-transaction
Indirect holdings after transaction
7,853 shares
Class A Common Stock held via Separate Property Trust
Remaining stock options
102,361 options
Stock Option (right to buy) remaining after exercise
10b5-1 plan adoption date
May 21, 2025
Date CFO adopted Rule 10b5-1 trading plan
Key Terms
Rule 10b5-1 trading plan, Stock Option (right to buy), Class A Common Stock, vesting, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) with conversion or exercise price of 5.0100"
Class A Common Stock financial
"security_title: Class A Common Stock for both the sale and the underlying security shares"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vesting financial
"25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security for the option transaction coded M"
FAQ
What insider transactions did HIMS CFO Oluyemi Okupe report?
CFO Oluyemi Okupe exercised stock options for 7,163 Class A Common shares at $5.0100 and sold 7,163 shares at an average price of $36.4863. The activity reflects an exercise-and-sell pattern tied to existing equity awards.
Were the HIMS insider transactions made under a Rule 10b5-1 plan?
Yes. The stock option exercises and related sales were executed under a Rule 10b5-1 trading plan adopted on May 21, 2025. Such plans pre-schedule trades, indicating the timing was determined in advance rather than based on short-term market conditions.
What stock options remain for the HIMS CFO after this Form 4 filing?
Following the option exercise of 7,163 shares, 102,361 stock options remain outstanding for CFO Oluyemi Okupe. These options carry a conversion or exercise price of $5.0100 per share and are scheduled to expire on February 23, 2032, subject to vesting terms.
How do the HIMS CFO’s insider sales compare to his total direct holdings?
The CFO sold 7,163 shares in this transaction while reporting 284,321 shares held directly afterward. This indicates the sale represents a small portion of his direct ownership, with the majority of his equity position remaining invested in Hims & Hers Health.
AI-generated analysis. How Rhea-AI works. Not financial advice.
